Ligand conjugated low-density lipoprotein nanoparticles for enhanced optical cancer imaging in vivo

Juan Chen, Ian R. Corbin, Hui Li, Weiguo Cao, Jerry D. Glickson, Gang Zheng

Research output: Contribution to journalArticle

91 Scopus citations

Abstract

LDL particles are high-capacity nanocarriers with precisely controlled size and are naturally biocompatible, biodegradable, and nonimmunogenic. However, their utilities as drug carriers are limited by the narrow purview of LDL receptor-positive tumors. Here, we synthsized a ligand-conjugated, NIR-labeled LDL that enables the first in vivo demonstration of rerouting LDL from LDL receptors to selected alternate receptors, thus drastically expanding the range of using LDL particles as nanocarriers for in vivo cancer imaging and treatment.

Original languageEnglish (US)
Pages (from-to)5798-5799
Number of pages2
JournalJournal of the American Chemical Society
Volume129
Issue number18
DOIs
StatePublished - May 9 2007

ASJC Scopus subject areas

  • Catalysis
  • Chemistry(all)
  • Biochemistry
  • Colloid and Surface Chemistry

Fingerprint Dive into the research topics of 'Ligand conjugated low-density lipoprotein nanoparticles for enhanced optical cancer imaging in vivo'. Together they form a unique fingerprint.

  • Cite this